Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- PILA.ST
- Price
- 3.46
- Stock movement down
- -0.01 (-0.14%)
- Company name
- Pila Pharma AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Biotechnology
- Market cap
- 93.99M
- Ent value
- 93.36M
- Price/Sales
- 89.60
- Price/Book
- 36.50
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 6.21%
- 1 year return
- 58.22%
- 3 year return
- -14.11%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-18
DIVIDENDS
PILA.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 89.60 |
| Price to Book | 36.50 |
| EV to Sales | 89.00 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 27.13M |
| EPS (TTM) | -0.29 |
| FCF per share (TTM) | -0.21 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.05M |
| Gross profit (TTM) | -4.20M |
| Operating income (TTM) | -6.88M |
| Net income (TTM) | -6.92M |
| EPS (TTM) | -0.29 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -400.19% |
| Operating margin (TTM) | -655.39% |
| Profit margin (TTM) | -659.39% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.54M |
| Net receivables | 0.00 |
| Total current assets | 2.81M |
| Goodwill | 0.00 |
| Intangible assets | 1.62M |
| Property, plant and equipment | 0.00 |
| Total assets | 4.49M |
| Accounts payable | 786.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.91M |
| Total liabilities | 1.91M |
| Shareholder's equity | 2.58M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -4.96M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -4.96M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -268.62% |
| Return on Assets | -154.16% |
| Return on Invested Capital | -268.62% |
| Cash Return on Invested Capital | -192.66% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3.46 |
| Daily high | 3.52 |
| Daily low | 3.46 |
| Daily Volume | 0K |
| All-time high | 12.11 |
| 1y analyst estimate | 7.32 |
| Beta | 0.55 |
| EPS (TTM) | -0.29 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PILA.ST | S&P500 | |
| Current price drop from All-time high | -71.39% | -14.12% |
| Highest price drop | -90.96% | -56.47% |
| Date of highest drop | 15 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -65.67% | -11.07% |
| Avg time to new high | 158 days | 12 days |
| Max time to new high | 934 days | 1805 days |
COMPANY DETAILS
Marketcap
93.99M
Marketcap category
Small-cap
Description
PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2b clinical trials for type 2 diabetes. The company was incorporated in 2014 and is based in Malmö, Sweden.
Employees
1
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found